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A 57-year-old man with a history of more than 10 years of bronchial asthma and chronic 
sinusitis complained of double vision which developed 18 days after cardiac tamponade with 
eosinophil-rich fluid (eosinophils 30%). He had oculomotor nerve palsy, and a blood test 
revealed eosinophilia (12,700/mm
3) and elevation of both C-reactive protein and 
rheumatoid factor. He was diagnosed as having Churg-Strauss syndrome. His symptoms 
were relieved by corticosteroid therapy. Our case and previous cases in the literature 
revealed that oculomotor nerve palsy in Churg-Strauss syndrome is associated with pupil 
involvement and may be relieved by corticosteroid treatment. 
 
Introduction 
Churg-Strauss syndrome (CSS) is a form of systemic vasculitis characterized by 
bronchial asthma, eosinophilia and necrotizing vasculitis [1]. CSS affects many organs 
such as the skin, kidneys, nerves, and lungs. Peripheral nerve involvement is common 
in CSS, but cranial nerve involvement is rare [2–4]. We present a case with CSS who 
developed oculomotor nerve palsy. Case Rep Neurol 2011;3:274–277 
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A 57-year-old Japanese man was admitted to our cardiology department complaining of dyspnea 
and fever that had developed 2 weeks prior to admission. He had a history of more than 10 years of 
bronchial asthma and sinusitis; his family history was unremarkable with regard to bronchial asthma 
and diabetes mellitus. His physical examination on admission revealed a body temperature of 38.5°C, 
a blood pressure of 117/73 mm Hg and a heart rate of 141 beats/min. Routine laboratory data 
demonstrated an increased white blood cell count of 14,990/mm3 (eosinophils 29.4%), lactate 
dehydrogenase 282 IU/l (normal 115–245), creatine kinase 99 IU/l (normal 12–142) and C-reactive 
protein (CRP) 9.2 mg/dl (normal <0.3). A subsequent transthoracic echocardiogram showed a large 
circumferential pericardial effusion and a small amount of bilateral pleural effusion. The patient was 
diagnosed as having cardiac tamponade associated with pneumonia, and daily intravenous 
administration of 6 g sulbactam/ampicillin was initiated. Pericardiocentesis was performed, and 
580 ml of yellowish fluid was extracted. Examination of the pericardial fluid revealed a white blood 
cell count of 17,625/mm3 (eosinophils 30%), total protein 5.5 g/dl (serum total protein 6.4 g/dl) and 
glucose 61 mg/dl (serum glucose 116 mg/dl). His dyspnea resolved after drainage, and his CRP level 
decreased to 3.9 mg/dl 13 days after admission. 
The patient developed double vision and a left ptosis 18 days after pericardiocentesis. He was 
diagnosed with oculomotor nerve palsy and was moved to the neurology department. His physical 
examination revealed a body temperature of 36.3°C, a blood pressure of 157/98 mm Hg and a heart 
rate of 98 beats/min upon his transfer to the neurology department. Left-sided ptosis was observed, 
and the left pupil was dilated and non-reactive to light. The left eye was in an abductive position, and 
movement was limited except for abduction (fig. 1). Other cranial nerves were normal. There was 
hypesthesia in the right chest and the left thigh. Muscular strength and reflex were normal. Blood 
laboratory data demonstrated a white blood cell count of 20,100/mm3 (eosinophils 12,700/mm3, 
63.2%), lactate dehydrogenase 476 IU/l, CRP 4.0 mg/dl, rheumatoid factor 711.6 IU/ml (normal <20) 
and complement C3 167 mg/dl (normal 86–160); myeloperoxidase-specific anti-neutrophil 
cytoplasmic antibody (MPO-ANCA), cytoplasmic staining anti-neutrophil cytoplasmic antibody and 
antinuclear antigen were all negative. Urinalysis was normal. The results of the cerebrospinal fluid 
examination were normal. A transthoracic echocardiogram showed a small amount of pericardial 
effusion and a small amount of bilateral pleural effusion. An MRI of the T2 and FLAIR sequences 
showed no abnormalities in the brain, including the brain stem, cavernous sinus and orbits. 
He was diagnosed as having CSS, and was given a 3-day course of pulse therapy with 1 g/day 
methylprednisolone, followed by 50 mg/day oral prednisolone. Ptosis, hypesthesia and eye 
movement improved along with pericarditis, and his eosinophil count and CRP level decreased to 
normal values 7 days after admission. The prednisolone dose was tapered over the following year, 
and remission was sustained with 3 mg/day prednisolone. Mild downward gaze palsy on the left side 
was sustained for more than 1 year. 
Discussion 
The criteria for CSS according to the American College of Rheumatology [5] include 
asthma, eosinophilia, extravascular eosinophilic involvement, neuropathy, sinus 
abnormality and pulmonary infiltrate, and our patient fulfilled the first five conditions. 
MPO-ANCA was not elevated in our patient, but its positive rate in CSS has been 
reported to be 60–70% [6]. 
The first manifestation of CSS in our patient was cardiac tamponade. Pericardial 
effusion has been found in 22–32% of CSS cases [2, 6], but severe pericarditis or cardiac 
tamponade as in our patient has rarely been reported [7, 8]. Our patient showed a 
negative MPO-ANCA, and it has been reported that cardiac manifestations are more 
common among ANCA-negative than ANCA-positive patients, the incidence ratios being 
36 and 7%, respectively [9]. ANCA may be relevant to organ vulnerability in CSS. Case Rep Neurol 2011;3:274–277 
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Treatment with corticosteroids has been reported to be beneficial for pericarditis in 
CSS [7, 8]. 
In our patient, unilateral oculomotor nerve palsy followed cardiac involvement. 
Association of sensory disturbances in the body may have presented multiple 
mononeuropathy. Frequent etiologies of acquired oculomotor nerve palsy are 
intracranial aneurysms and tumors, meningeal lymphoma, diabetes mellitus, Tolosa-
Hunt syndrome, and others. Cranial nerve involvement is found in 3.1–16% of CSS 
patients: optic neuropathy is the most common [2, 4], but oculomotor nerve palsy is 
very rare. We found 4 detailed case reports of CSS patients manifesting oculomotor 
nerve palsy in the literature (see online suppl. table 1, 
www.karger.com/doi/10.1159/000334127) [10–13]. The pupils were involved in all of 
the described cases, including our patient; this contrasts with diabetic oculomotor 
nerve palsy, in which the pupils are usually spared. The pupil involvement suggests 
that the damage to the oculomotor nerve in CSS is more severe than in diabetes, and 
this difference may be due to pathogenetic difference. With respect to associated 
symptoms, periorbital pain was not observed in all cases, contrasting with Tolosa-Hunt 
syndrome. Brain MRI was performed in 3 cases, including ours; it showed no 
abnormality in 2 cases and midbrain infarction in 1 case. No histological examination 
was carried out. Treatment with corticosteroids was successful in all of the described 
cases, but a partial paresis of the oculomotor nerve was sustained as a sequela in our 
patient. 
In conclusion, CSS is one of the causative diseases of oculomotor nerve palsy. While 
the presence of periorbital pain is less frequent, the pupil is very often involved. Early 







Fig. 1. Photographs of ocular positions showing complete left oculomotor nerve palsy associated with 
a severe ptosis and pupil dilatation. 
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